Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? - Wikidata - wikimedia - TriplyDB

Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?

Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?

http://www.wikidata.org/entity/Q43238303

about

Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.The Necrosis-Avid Small Molecule HQ4-DTPA as a Multimodal Imaging Agent for Monitoring Radiation Therapy-Induced Tumor Cell Death.Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties Nitroxyl radicals-modified dendritic poly(l-lysine) as a contrast agent for Overhauser-enhanced MRI.Maternal-placental-fetal biodistribution of multimodal polymeric nanoparticles in a pregnant rat model in mid and late gestation.Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery.Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Lipid nanoparticles for gene delivery.Fluorescent Labeling and Biodistribution of Latex Nanoparticles Formed by Surfactant-Free RAFT Emulsion Polymerization.Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine).Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.Comprehensive characterizations of nanoparticle biodistribution following systemic injection in mice.Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo.In Vivo Imaging of Glycol Chitosan-Based Nanogel Biodistribution.Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles

P2860

Q26746186-FFFEFF13-68C0-4629-A653-8D77C14A425E Q30370566-03AA1410-CF3F-41BF-9092-128A970AF3C9 Q30744724-FA5D86C7-18B9-4EFE-AFBE-AB5CA6D05CC4 Q30840493-513D547C-66DC-46F0-9FEF-3AD1EA2CE4A9 Q33767418-FA62B035-DF88-48AC-AD4D-BCE5B4704C6C Q33908258-441518F6-BBE4-4E41-B58E-BA1EDC5CF40B Q34447986-4B180C4A-91CA-457E-8D11-94741C865596 Q35883228-7209538A-4909-4128-B97A-8BD7954A23F6 Q36505631-C8B24565-89A7-434E-91E8-BC85D597BA74 Q36907352-F1F8EDC1-B468-49FF-8257-DF4C282FBBC9 Q37031613-FADF20EB-B15F-462E-85A7-D15010EF851D Q37229892-44C831B0-0AEC-492A-842F-7570F7613A42 Q37251480-9E7B319B-F558-4345-A777-23FF1AF7EF6C Q37455236-B06E75BA-B513-490E-A4B2-839C20B54CBF Q37588032-8D00E372-0E3B-485C-B5AC-F4BEC080B380 Q38269555-4320666D-1124-4F99-B73B-83C2AC752363 Q38726239-CEAEAB48-D813-49B3-8568-338FAFAB6AF5 Q38973975-B1479DA0-48A0-498A-88F3-9023F1C439DF Q39122521-996233DD-B42E-4230-B2D7-E5B83C6F848B Q39343741-D05CC7B3-6CDA-4649-ABE7-B92D53FCB2B4 Q47322840-518DEE62-03AC-44A2-B6F3-98C6F7E79A0D Q50048515-97D8E1D8-06E2-4262-A0D2-5AE09BF331BA Q51607973-88F2073B-1BBE-480E-90EA-B6CA6B29D5DA Q57181636-0F95361C-88C8-47D9-80B9-B8EF51937CE0

P2860

Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?

http://www.wikidata.org/entity/Q43238303

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Biodistribution studies of nan ...... tative or quantitative method?

@en

Biodistribution studies of nan ...... tative or quantitative method?

@nl

type

label

Biodistribution studies of nan ...... tative or quantitative method?

@en

Biodistribution studies of nan ...... tative or quantitative method?

@nl

prefLabel

Biodistribution studies of nan ...... tative or quantitative method?

@en

Biodistribution studies of nan ...... tative or quantitative method?

@nl

P1433

Q43238303-93529709-F0AF-488D-9D71-84CD5F27AA73

P1476

Q43238303-1FECA357-FE08-4CB3-805F-473FBEB00D30

P2093

Q43238303-7E80EDBE-BA24-4C0A-851D-F38EFFDCAB03

Q43238303-B317A1C1-38DB-4245-B45C-CC5399E24B11

Q43238303-D0026D43-C98F-411A-8DA7-A685D961FC35

P2860

Q43238303-0053DB74-0B88-4263-96AD-CD5D22296D11

Q43238303-4D055F8A-F7D0-4331-8FD2-066C858F6E4B

Q43238303-4D944254-4B57-4EF1-9068-4304AF9ED393

Q43238303-6BE02069-F484-4A5E-91E8-7F60EE5F5DBB

Q43238303-7F7F7E74-8546-46B2-B048-D2E6705A46D4

Q43238303-98460D6F-739D-4C91-8C42-768EFA79A902

Q43238303-9DE7D317-E936-453E-B630-7F38988F7F15

Q43238303-AF7E8D53-84C1-4D99-95A7-BADE0D59BBCF

Q43238303-C7E72B6C-D722-45B5-96B0-A6DD5C331BD4

Q43238303-C9A2480E-4F07-45FD-AB32-6FC84EBD9377

P304

Q43238303-47C2EEB5-D4A2-48F2-A6B1-DD99D4A950AF

P31

Q43238303-C18098EF-2BE8-4241-9931-BC4D2BC1CFB5

P356

Q43238303-37C95DC0-06D6-498F-8CEE-2597B98AD634

P433

Q43238303-FE5B8D11-34D5-48FC-B45C-6239ACD5A887

P478

Q43238303-A599E330-F543-423E-8F98-0927DDE7657D

P577

Q43238303-7838CD46-A040-4EA4-9C74-CF278F7BA047

P698

Q43238303-882587C8-AB86-4AAA-9D17-D1121FE65D53

P921

Q43238303-83F4418C-3121-4D72-B3F8-EFA3C0D61954

P932

Q43238303-6D84CB49-13EE-4A3F-A809-E752976AAF24

P356

S11095-012-0818-1

P1433

Pharmaceutical Research

P1476

Biodistribution studies of nan ...... tative or quantitative method?

@en

P2093

Leaf Huang

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Yu-Cheng Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.

Challenges to macromolecular drug delivery.

Applications of mass spectrometry to the study of siRNA.

In vivo near-infrared fluorescence imaging.

Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.

Tritium labeling of antisense oligonucleotides by exchange with tritiated water.

Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.

Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor

Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.

Fluorescence imaging of tumors in vivo.

P304

3273-3277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-012-0818-1

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22806405

http://www.w3.org/2001/XMLSchema#string

P921

P932

3584332

http://www.w3.org/2001/XMLSchema#string